
Opinion|Videos|August 2, 2024
High-Risk Populations for Severe Pneumococcal Infection
Key opinion leaders identify high-risk populations for invasive pneumococcal disease, explain the underlying factors contributing to their increased susceptibility, and offer strategies to improve suboptimal vaccination rates, particularly among historically underserved communities.
Advertisement
Episodes in this series

- Who are the high-risk
populations for developing invasive pneumococcal disease?- What is the rationale for why certain populations are at risk for severe pneumococcal infections?
- How can we improve inadequate pneumococcal vaccine uptake rates, specifically in historically marginalized groups?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Federal Health Officials Scale Back Number of Recommended Vaccines for Children
2
Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy
3
GoodRx Expands Access to Oral GLP-1 Therapy With Semaglutide Pill Cash Pricing
4
Toothpaste Tablets Are Gaining Popularity—Here’s Where Pharmacists Fit In
5












































































































































































































